Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
MicroRNA 7156 (MIR7156) is classified as a microRNA, a short non-coding RNA molecule (typically 20-24 nucleotides) that regulates gene expression by binding to target mRNAs, resulting in their translational inhibition or destabilization. MicroRNAs, including MIR7156, are transcribed by RNA polymerase II as part of longer primary transcripts, processed into precursor miRNAs by Drosha, and finally into mature miRNAs via Dicer. The mature microRNA functions by incorporating into the RNA-induced silencing complex (RISC), directing the complex to specific mRNAs for regulation[2]. As of now, MIR7156 does not have established disease associations, recognized interacting drugs, mechanisms of drug action, or biomarker utility listed in major databases. There is limited or no published functional or clinical information supporting its status as a therapeutic target.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on MicroRNA 7156 (MIR7156).